8MV0 — Bioharvest Sciences Balance Sheet
0.000.00%
Last trade - 00:00- €82.51m
- €74.94m
- $34.51m
Annual balance sheet for Bioharvest Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.12 | 1.74 | 5.36 | 2.39 | 23 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.62 | 1.21 | 0.957 | 1.37 | 2.32 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 5.67 | 4.32 | 9.05 | 7.86 | 30.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4.36 | 4.91 | 5.77 | 16.8 | 16.7 |
| Other Long Term Assets | |||||
| Total Assets | 10.2 | 9.39 | 15 | 25 | 47.7 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.92 | 11.5 | 26.5 | 14.3 | 7.68 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.35 | 15.3 | 29.9 | 23.7 | 22.2 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 2.85 | -5.93 | -14.9 | 1.33 | 25.4 |
| Total Liabilities & Shareholders' Equity | 10.2 | 9.39 | 15 | 25 | 47.7 |
| Total Common Shares Outstanding |